Stryker Corporation Buyback
OLI recorded this information on 3/3/2015
Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has authorized a new $2 billion share repurchase program. The program is in addition to $583 million of existing authorization remaining under the Company's current share repurchase programs, bringing the Company's total share repurchase authorization to $2.583 billion.
Stryker is a medical technology company. Co. provides products and services in orthopaedics, medical and surgical, and neurotechnology and spine. Orthopaedics products include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products and reprocessed and remanufactured medical devices. Neurotechnology and Spine products include neurosurgical, neurovascular, craniomaxillofacial and spinal implant devices.
Stryker SEC Filing Email Alerts Service
Open the SYK Page at The Online Investor »
Buy (3.11 out of 4)